Ovid Therapeutics
(NASDAQ:OVID)
$3.01
-0.01[-0.33%]
Last update: 11:20AM Get Real Time Here
Q1 2024 earnings were released today before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Ovid Therapeutics Stock (NASDAQ:OVID), Quotes and News Summary

Ovid Therapeutics Stock (NASDAQ: OVID) stock price, news, charts, stock research, profile.

Open$3.000
Close-
Volume / Avg.35.007K / 202.830K
Day Range2.990 - 3.050
52 Wk Range2.570 - 4.139
Market Cap$213.140M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
46
Short Interest
4.8%
Days to Cover22.66

Recent News

Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Avi Kapoor
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this week.
Vandana Singh
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating risks to millions of people," including those in states where abortion remains legal.
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
3
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
OVID
ZURA

FAQ

Q

How do I buy Ovid Therapeutics (OVID) stock?

A

You can purchase shares of Ovid Therapeutics (NASDAQ: OVID) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Ovid Therapeutics's (OVID) competitors?

A

Other companies in Ovid Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Innate Pharma (NASDAQ:IPHA), bluebird bio (NASDAQ:BLUE), Agenus (NASDAQ:AGEN) and Lineage Cell Therapeutics (AMEX:LCTX).

Q

What is the target price for Ovid Therapeutics (OVID) stock?

A

The latest price target for Ovid Therapeutics (NASDAQ: OVID) was reported by Citigroup on Tuesday, May 7, 2024. The analyst firm set a price target for 3.50 expecting OVID to rise to within 12 months (a possible 16.28% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Ovid Therapeutics (OVID)?

A

The stock price for Ovid Therapeutics (NASDAQ: OVID) is $3.01 last updated Today at May 14, 2024 at 11:20 AM EDT.

Q

Does Ovid Therapeutics (OVID) pay a dividend?

A

There are no upcoming dividends for Ovid Therapeutics.

Q

When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?

A

Ovid Therapeutics’s Q2 earnings are confirmed for Friday, August 2, 2024.

Q

Is Ovid Therapeutics (OVID) going to split?

A

There is no upcoming split for Ovid Therapeutics.

Q

What sector and industry does Ovid Therapeutics (OVID) operate in?

A

Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch